TY  - JOUR

T1  - “Mendelian randomisation and experimental medicine approaches to interleukin-6 as a drug target in pulmonary arterial hypertension.” Mark Toshner, Colin Church, Lars Harbaum,
                    <i>et al</i>
                    .
                    <i>Eur Respir J</i>
                    2022; 59: 2002463.

JO  - European Respiratory Journal

UR  - https://doi.org/10.1183/13993003.52463-2020

PY  - 2022/07/07

AU  - 

ED  - 

DO  - DOI: 10.1183/13993003.52463-2020

PB  - European Respiratory Society (ERS)

VL  - 60

IS  - 1

SP  - 2052463

EP  - 2052463

Y2  - 2026/08/14

ER  -